Genentech News

CAMBRIDGE, Mass. -- -- Ensemble Therapeutics, a biotechnology company developing EnsemblinsTM, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group , to discover macrocyclic drug candidates against targets specified by ... (more)

The Obama administration has announced a bold research program to test whether a drug can prevent the onset of Alzheimer's disease well before any symptoms appear.

From the University of Washington , Group Health Research Institute , Genentech, Inc.

Three years after outsiders worried that Roche's $47 billion buyout would downgrade the company's revered research group, the Food and Drug Administration next month could give the legendary South San Francisco biotech company its third drug approval in the past 10 months.

David Ebersman's career has been something of a fairy tale. Brown University, research analyst on Wall Street, and a stellar 15-year stint at Genentech, the world's premier biotech company.

A Ferry service will launch on June 4 between South San Francisco and the East Bay, and for the first week, trips will be free.

Genentech has been awarded the right to run a trial on an experimental drug that could cure Alzheimer's, a disease that currently has no known cure.

A Ferry service will launch on June 4 between South San Francisco and the East Bay, and for the first week, trips will be free.

Genentech, a member of the Roche Group , today announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology , June 1 to 5, 2012, in Chicago.

East Bay commuters will be able to ferry to South San Francisco beginning June 4 on weekdays during peak commute hours.

Roche's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia -- the first such trial to gauge whether early intervention can help prevent or slow the disease.

PLEASANTON, Calif. -- -- IntegenX Inc., a privately held company and leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products, today announced the appointment of David V. Smith as Chief Operating Officer.

San Francisco - A Florida mother made an impassioned video plea. Dying of breast cancer, she asked South San Francisco drugmaker Genentech and federal regulators to grant her " The woman, Darlene Gant, 46, looked into the camera and said she didn't have much time.

A number of other analysts have also recently weighed in on RHHBY. Analysts at JPMorgan Chase downgraded shares of Roche Holding from an "overweight" rating to a "neutral" rating in a research note to investors on Tuesday.

LEXINGTON, Mass. -- Drug developer Curis Inc. said Tuesday that it turned a first-quarter profit after federal regulators approved its skin cancer treatment Erivedge early in the period.

Pillsbury & Levinson LLP has hired Ingrid Leverett as special counsel. Leverett was an attorney with the Ninth Circuit U.S. Court of Appeals, serving as supervisor of the civil unit.

I haven't met Ebersman personally yet, but in the context of doing some research on Facebook , I asked a lot of people about him.

Sutro Biopharma CEO William Newell , shown with Chief Scientific Officer Trevor Hallam, says the company's antibody-drug conjugate technology could net a couple of partnerships over the next 12 to 18 months.

Separately, analysts at Citigroup downgraded shares of Roche Holding from a "buy" rating to a "neutral" rating in a research note to investors on Tuesday, February 14th.

Stock markets recovered around the world following an early stumble caused by election results in France and Greece that appeared to jeopardize Europe's plans for fighting its debt crisis.